Skip to main navigation Skip to search Skip to main content

informed Decision-Making and capabilities in Population-based cancer screening

  • Ineke L. L. E. Bolt*
  • , Maartje H. N. Schermer
  • , Hanna Bomhof-Roordink
  • , Danielle R. M. Timmermans
  • *Corresponding author for this work
  • Erasmus University Rotterdam

Research output: Contribution to journalArticleAcademicpeer-review

74 Downloads (Pure)

Abstract

Informed decision-making (IDM) is considered an important ethical and legal requirement for population-based screening. Governments offering such screening have a duty to enable invitees to make informed decisions regarding participation. Various views exist on how to define and measure IDM in different screening programmes. In this paper we first address the question which components should be part of IDM in the context of cancer screening. Departing from two diverging interpretations of the value of autonomy—as a right and as an ideal—we describe how this value is operationalized in the practice of informed consent in medicine and translate this to IDM in population-based cancer screening. Next, we specify components of IDM, which is voluntariness and the requirements of disclosure and understanding. We argue that whereas disclosure should contain all information considered relevant in order to enable authentic IDM, understanding of basic information is sufficient for a valid IDM. In the second part of the paper we apply the capability approach in order to argue for the responsibility of the government to warrant equal and real opportunities for invitees for IDM. We argue that additional conditions beyond mere provision of information are needed in order to do so.
Original languageEnglish
Pages (from-to)289-300
JournalPUBLIC HEALTH ETHICS
Volume15
Issue number3
DOIs
Publication statusPublished - 1 Nov 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'informed Decision-Making and capabilities in Population-based cancer screening'. Together they form a unique fingerprint.

Cite this